Navigation Links
Gladstone's Shinya Yamanaka wins Lasker Award
Date:9/14/2009

Shinya Yamanaka, MD, PhD, of the Gladstone Institute of Cardiovascular Disease (GICD) and Kyoto University, has won the 2009 Albert Lasker Basic Medical Research Award for his discovery of a method of reprogramming adult skin cells to become embryonic-like stem cells. Yamanaka, who is the L.K.Whittier Investigator in Stem Cell Biology at Gladstone, and professor of anatomy at UCSF, is one of the youngest recipients of the award, which is seen as a precursor to the Nobel Prize.

Yamanaka's discovery was made just three years ago and has created significant momentum in the field of stem cell research. He shares the Lasker Award with John Gurdon of Cambridge University who in the 1950s established the genetic principles of cells that ignited the field of "nuclear reprogramming," which in turn led to Scottish scientists cloning Dolly the sheep in 1997.

"I'm extremely honored to be recognized by the Lasker Foundation and share this award with Dr. Gurdon, who established the basis for my discoveries," Yamanaka said. "I'm gratified that the area of stem cell research has opened up and accelerated to more quickly bring the benefits of this technology to patients."

While other scientists continued to experiment with a traditional approach to learn how embryonic stem cells differentiate to become different kind of cells, Dr. Yamanaka and his team took what was considered a contrarian approach to learn how differentiated adult cells might be reprogrammed back to their embryonic or "pluripotent" state. Yamanaka and his colleagues found that by introducing four genetic factors, skin cells from an adult would transform into cells that behaved just like embryonic stem (ES) cells, and he coined the term "induced pluripotent stem cells" or iPS cells. The simplicity of Yamanaka's technology was initially met with skepticism, but Yamanaka made his data and the DNA of his work publicly available to enable any scientist to work with these new cells, and within months scientists across the world had reproduced and adopted this new approach to generating and studying stem cells.

Yamanaka's discovery not only obviated the many of the restrictions on stem cell research by eliminating the use of human embryos," said Deepak Srivastava, MD, GICD director, "but it fundamentally altered the way we think about how cells can alter their state so dramatically with a skin cell ultimately turning into a beating heart cell."

Since Yamanaka's discovery, both he and other scientists have learned more efficient ways to make iPS cells and have used them to create other types of cells including neurons, heart cells etc. Many have made iPS cells from patients with disease and hope to use these human cells to model the disease, so that new drug therapies could be discovered to alleviate human suffering.

"The technology is for patients," Yamanaka said, "and the more scientists build on this technology, the faster we will impact those who live with chronic or life-threatening disease."

"Dr. Yamanaka's work has, in a very short time, changed stem cell research from a very early stage experimental process to a field where we can see very real potential of repairing damaged hearts, spinal cords or curing certain diseases, like diabetes," said Gladstone president Robert W. Mahley, MD, PhD.

"That his achievement is being recognized by the Lasker Foundation underscores the pace at which this field is now moving forward."

With 76 prior Lasker laureates going on to receive the Nobel Prize, the award is recognized as a precursor to earning that honor. Yamanaka has already received the Shaw Prize which is seen as the "Asian" Nobel and the Gairdner Award which is known as the "Baby Nobel."


'/>"/>

Contact: Valerie Tucker
vtucker@gladstone.ucsf.edu
415-734-2019
Gladstone Institutes
Source:Eurekalert  

Related biology news :

1. Gladstones Shinya Yamanaka wins prestigious Shaw Prize
2. Yamanaka eliminates viral vector in stem cell reprogramming
3. Anthony S. Fauci awarded Lasker Award for Public Service
4. MGH researcher Gary Ruvkun named a co-recipient of the Lasker Award
5. ESF EURYI award winner aims to stop cancer cells reading their own DNA
6. The American Society of Plant Biologists announces 2007 awards
7. Minimally invasive heart surgery research wins NIH award
8. 12 McGill researchers awarded Canada Research Chairs
9. Herr receives Heinz Award for Technology, the Economy and Employment
10. Singapore National Science and Technology Awards
11. RSC Project Prospect scoops prestigious award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Gladstone's Shinya Yamanaka wins Lasker Award
(Date:1/18/2016)... , Jan. 18, 2016  Extenua Inc., ... that simplifies the use and access of ubiquitous ... go-to-market partnership with American Cyber.  ... extensive experience leading transformational C4ISR and Cyber initiatives ... integrating the latest proven technology solutions," said ...
(Date:1/13/2016)... , January 13, 2016 /PRNewswire/ ... announced the addition of the  "India ... Estimation & Forecast (2015-2020)"  report ... http://www.researchandmarkets.com/research/7h6hnn/india_biometrics ) has announced the addition ... Identification Market - Estimation & Forecast ...
(Date:1/8/2016)... and MANCHESTER, United Kingdom , Jan. 8, ... of innovative sensor-based diagnostic products, today announced the closing of ... and existing investors.  Proceeds from the financing will be used ... a hand-held device for detecting early-stage pressure ulcers. ... after receiving CE Mark approval. The device,s introduction ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... ... February 04, 2016 , ... Franz Inc. , an ... technology has been recognized As “ Best in Semantic Web Technology - USA ... Corporate America, it’s our priority to showcase prominent professionals who are excelling in ...
(Date:2/3/2016)... , Feb. 3, 2016  With the ... patent cliff that is underway, therapies such as ... for a whole host of indications are in ... aid in the development and production of these ... poor quality and high costs, novel approaches and ...
(Date:2/3/2016)... ... February 03, 2016 , ... ProMIS Neurosciences is currently in ... to misfolded, propagating strains of Amyloid beta involved in Alzheimer’s disease. The Company ... , Following on from the first misfolded Amyloid beta target announced on Nov. ...
(Date:2/3/2016)... , ... February 03, 2016 , ... ... to aid in the rapid development and ongoing quality control of molecular assays ... outbreak is extremely high,” Dr. Gregory R. Chiklis, President and CEO of ZeptoMetrix, ...
Breaking Biology Technology: